3 Best Stocks to Buy Now, 9/15/2023, According to Top Analysts
Stock Analysis & Ideas

3 Best Stocks to Buy Now, 9/15/2023, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts.

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

CVS Health (NYSE:CVS– CVS Health owns a retail pharmacy chain and operates as a pharmacy benefits manager and health insurance provider. Yesterday, Cantor Fitzgerald analyst Sarah James reiterated a Buy rating on the stock with a price target of $87. Interestingly, nine out of 10 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of over 37%.

Cantaloupe (NASDAQ:CTLP– Cantaloupe is a digital payments and software services company. Yesterday, Barrington analyst Gary Prestopino reaffirmed a Buy rating on the stock with a price target of $10. CTLP stock has received Buy recommendations from all three Top Analysts who have recently rated it. Overall, the consensus 12-month price target suggests an increase of about 71%.

DocGo (NASDAQ:DCGO– DocGo provides mobile health and medical transportation services for various healthcare providers. Yesterday, Northland Securities analyst Michael Latimore maintained a Buy rating on the stock with a price target of $16. All four Top Analysts who recently rated the stock gave it a Buy. Collectively, their 12-month price targets imply an upside of nearly 113%.

Who are the Top Analysts?

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page.

Disclosure

Related Articles
TheFlyCVS Health price target lowered to $58 from $68 at RBC Capital
TheFlyMcKesson, Oracle among finalists looking to buy Veradigm, Axios reports
TheFlyCVS Health price target lowered to $71 from $75 at Barclays
Go Ad-Free with Our App